‹ Startups
Startup
Cambridge Epigenetix
Cambridge Epigenetix is using epigenetics to reduce diagnostic tests for common cancers to a simple blood draw.
About
No description yet.
Funding rounds
Series D
Sequoia
$88.0M
Jan 1, 2021
Cambridge Epigenetix is using epigenetics to reduce diagnostic tests for common cancers to a simple blood draw.
No description yet.